Sarepta Therapeutics (SRPT)

• Market cap: $2.44B
• 1 day: 1.3%
• 5 days: 7.41%
• 1 month: 25.2%
• 3 months: 75.3%
• 6 months: -57.72%
• Year to date: -81.18%
• 1 year: -81.66%
• 5 years: -82.99%
• 10 years: -9.95%
• Sector: Healthcare
• Industry: Biotechnology

About: Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Employees: 1,372